Literature DB >> 19641221

C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2.

Lambertus H C Van Lith1, Julia Oosterom, Andrea Van Elsas, Guido J R Zaman.   

Abstract

C5L2 (or GPR77) is a high-affinity receptor for the complement fragment C5a and its desarginated product, C5a-desArg. Unlike the classical C5a receptor CD88, C5L2 does not couple to intracellular G-protein-signaling pathways but is thought to function as a decoy receptor. The authors show that stimulation of C5L2 with C5a and C5a-desArg induces redistribution of green fluorescent protein-labeled beta-arrestin2 to cytoplasmic vesicles. C3a and C3a-desArg were inactive in the beta-arrestin translocation assay. Direct interaction of ligand-stimulated C5L2 with beta-arrestin was confirmed using a novel beta-galactosidase fragment complementation assay. In this assay, C5L2 was labeled with a mutationally altered peptide fragment of beta-galactosidase, whereas beta-arrestin2 was labeled with a corresponding deletion mutant of the enzyme. Stable transfection of the modified C5L2 and subsequent stimulation with C5a or C5a-desArg restored beta-galactosidase activity in a dose-dependent manner. The subnanomolar potency of beta-arrestin coupling in the beta-galactosidase fragment complementation assay is in agreement with the affinity of the receptor-ligand interaction. C5L2 is the first example of a 7-transmembrane decoy receptor that couples to beta-arrestin in a ligand-dependent manner. This observation supports the notion that G-protein-signaling and beta-arrestin coupling can be 2 separate activities of 7-transmembrane receptors. Furthermore, the beta-arrestin assays described in this article provide methods of screening for selective C5L2 modulators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641221     DOI: 10.1177/1087057109341407

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  14 in total

Review 1.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

2.  Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.

Authors:  Daniel E Croker; Peter N Monk; Reena Halai; Geraldine Kaeslin; Zoe Schofield; Mike Cl Wu; Richard J Clark; Mark At Blaskovich; Dimitrios Morikis; Christodoulos A Floudas; Matthew A Cooper; Trent M Woodruff
Journal:  Immunol Cell Biol       Date:  2016-04-25       Impact factor: 5.126

3.  β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.

Authors:  Anne O Watts; Folkert Verkaar; Miranda M C van der Lee; Claudia A W Timmerman; Martien Kuijer; Jody van Offenbeek; Lambertus H C J van Lith; Martine J Smit; Rob Leurs; Guido J R Zaman; Henry F Vischer
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

4.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  C5a receptor (CD88) inhibition improves hypothermia-induced neuroprotection in an in vitro ischemic model.

Authors:  John Thundyil; Dale Pavlovski; Yu-Hsuan Hsieh; Mathias Gelderblom; Tim Magnus; David P Fairlie; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2012-01-17       Impact factor: 3.843

6.  The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.

Authors:  Claire E Bamberg; Charles R Mackay; Hyun Lee; David Zahra; Jenny Jackson; Yun Si Lim; Peter L Whitfeld; Stewart Craig; Erin Corsini; Bao Lu; Craig Gerard; Norma P Gerard
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

7.  Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.

Authors:  Shubhi Pandey; Xaria X Li; Ashish Srivastava; Mithu Baidya; Punita Kumari; Hemlata Dwivedi; Madhu Chaturvedi; Eshan Ghosh; Trent M Woodruff; Arun K Shukla
Journal:  J Biol Chem       Date:  2019-04-29       Impact factor: 5.157

8.  Targeting the Dark Horse of complement: the first generation of functionally selective C5aR2 ligands.

Authors:  Claudia Kemper
Journal:  Immunol Cell Biol       Date:  2016-07-26       Impact factor: 5.126

Review 9.  The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.

Authors:  Ting Zhang; Malgorzata A Garstka; Ke Li
Journal:  J Immunol Res       Date:  2017-06-15       Impact factor: 4.818

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.